Definium Therapeutics (DFTX) Tax Provisions (2021)
Definium Therapeutics (DFTX) reported Tax Provisions of -$1.2 million for Q4 2021.
Definium Therapeutics (DFTX) Tax Provisions (2021) Analysis & Trends
Definium Therapeutics (DFTX) has 1 years of Tax Provisions data on file, last reported at -$1.2 million in Q4 2021.
- Tax Provisions for Q4 2021 came in at -$1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Sep 2022 was -$1.2 million (changed N/A YoY), and the FY2021 annual result was -$1.2 million, changed N/A from the prior year.
- Tax Provisions steadied at -$1.2 million in Q4 2021 per DFTX's latest filing.
- Over five years, Tax Provisions peaked at -$1.2 million in Q4 2021 and troughed at -$1.2 million in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Definium Therapeutics | 2.46 Bn | 2.09 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -1.16 Mn |